Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Lipton

Showing results (51-60 of 148) with videos related to

Pageof 15
Sort By:
Cancer|January 15, 2011
Zoledronic acid use in cancer patients: more than just supportive care?Robert Coleman, Richard Cook, Vera Hirsh, et al.
American Journal of Clinical Oncology|August 7, 2003
Effect of the combination of docetaxel, zoledronic acid, and a COX-2 inhibitor on the growth of human breast cancer cell linesLois M Witters, Jamie Crispino, Terri Fraterrigo, et al.
International Journal of Clinical Oncology|May 11, 2012
Treatment of bone metastases before the onset of painLuis Costa, Allan Lipton, Peyman Hadji, et al.
Breast Cancer Research : BCR|June 15, 2007
HER-2/neu diagnostics in breast cancerWalter P Carney, Kim Leitzel, Suhail Ali, et al.
Journal of Clinical Gastroenterology|March 11, 2010
Phase II trial of gemcitabine, irinotecan, and celecoxib in patients with advanced pancreatic cancerAllan Lipton, Cynthia Campbell-Baird, Lois Witters, et al.
Cancer Treatment Reviews|May 20, 2008
Bone loss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategiesRobert E Coleman, Jean-Jacques Body, Julie R Gralow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 7, 2012
Serum lactate dehydrogenase is prognostic for survival in patients with bone metastases from breast cancer: a retrospective analysis in bisphosphonate-treated patientsJanet E Brown, Richard J Cook, Allan Lipton, et al.
Oncology (Williston Park, N.Y.)|February 3, 2005
Gemcitabine/Irinotecan/celecoxib in pancreatic cancerAllan Lipton, Harold Harvey, Lois Witters, et al.
American Journal of Clinical Oncology|February 11, 2003
Decreased response to paclitaxel versus docetaxel in HER-2/neu transfected human breast cancer cellsLois M Witters, Samuel M Santala, Linda Engle, et al.
International Journal of Oncology|January 16, 2003
Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCRLoren E Clarke, Kim Leitzel, Jill Smith, et al.
Pageof 15

Showing results (51-60 of 148) with videos related to

Sort By:
Pageof 15
Cancer|January 15, 2011
Zoledronic acid use in cancer patients: more than just supportive care?Robert Coleman, Richard Cook, Vera Hirsh, et al.
American Journal of Clinical Oncology|August 7, 2003
Effect of the combination of docetaxel, zoledronic acid, and a COX-2 inhibitor on the growth of human breast cancer cell linesLois M Witters, Jamie Crispino, Terri Fraterrigo, et al.
International Journal of Clinical Oncology|May 11, 2012
Treatment of bone metastases before the onset of painLuis Costa, Allan Lipton, Peyman Hadji, et al.
Breast Cancer Research : BCR|June 15, 2007
HER-2/neu diagnostics in breast cancerWalter P Carney, Kim Leitzel, Suhail Ali, et al.
Journal of Clinical Gastroenterology|March 11, 2010
Phase II trial of gemcitabine, irinotecan, and celecoxib in patients with advanced pancreatic cancerAllan Lipton, Cynthia Campbell-Baird, Lois Witters, et al.
Cancer Treatment Reviews|May 20, 2008
Bone loss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategiesRobert E Coleman, Jean-Jacques Body, Julie R Gralow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 7, 2012
Serum lactate dehydrogenase is prognostic for survival in patients with bone metastases from breast cancer: a retrospective analysis in bisphosphonate-treated patientsJanet E Brown, Richard J Cook, Allan Lipton, et al.
Oncology (Williston Park, N.Y.)|February 3, 2005
Gemcitabine/Irinotecan/celecoxib in pancreatic cancerAllan Lipton, Harold Harvey, Lois Witters, et al.
American Journal of Clinical Oncology|February 11, 2003
Decreased response to paclitaxel versus docetaxel in HER-2/neu transfected human breast cancer cellsLois M Witters, Samuel M Santala, Linda Engle, et al.
International Journal of Oncology|January 16, 2003
Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCRLoren E Clarke, Kim Leitzel, Jill Smith, et al.
Pageof 15